Studies have shown that the histone acetyltransferase activity of CBP (KAT3A) is required for neurogenesis and memory formation and have also suggested that increasing CBP expression could be a viable treatment for AD [107,156,157]. The gene discussed is CREBBP; the disease is Alzheimer disease.